Home › Trial NCT01153906
Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination
- Trial IDNCT01153906
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorGlaxoSmithKline
- Enrollment1516
- Start date2010-10
- ConditionsInfections, Papillomavirus
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.